Acesion Pharma Announces Positive Pre-Clinical Data for AP31969
COPENHAGEN, Denmark, May 15, 2023. Acesion Pharma ( " Acesion " or " the Company " ), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ( " AF " ), the most common cardiac arrhythmia, today announces positive data from... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 15, 2023 Category: Pharmaceuticals Source Type: clinical trials

Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias
Condition:   Cardiac Arrhythmia Intervention:   Device: ACORYS MAPPING SYSTEM Sponsors:   Corify Care S.L.;   Hospital General Universitario Gregorio Marañon;   Hospital Clinic of Barcelona;   Hospital Universitario La Fe Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2023 Category: Research Source Type: clinical trials